The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...
M&As are stressful for multiple reasons, including role changes and getting laid off when staffs combine. Two talent experts ...
Looking for a biopharma job in New Jersey? Check out the BioSpace list of eight companies hiring life sciences professionals ...
The U.S. Court of Federal Claims ruled that Vanda cannot claim a breach of confidentiality for specifications that it did not ...
Turn your career aspirations into reality with this step-by-step guide to creating and implementing a strategic professional ...
The deal follows a $1.06 billion U.S. contract in July 2024 and a $1.24 billion agreement with an Asia-based pharma a few months later.
At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...
Cebranopadol, a dual-NMR agonist, reached the primary endpoint in a Phase III trial and matched placebo for safety, a ...
On the company’s Q4 earnings call where an eyepopping $88.8 billion in full-year sales were revealed, leaders shifted focus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback